These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1108460)

  • 21. [The anti-atherosclerotic effect of metformin in the initial phases of diabetes mellitus in adults].
    Baraldi B; Maestri G; Cusimano A; Valenti C; Tiraboschi L; Cocuzza E; Angeli G
    Clin Ter; 1980 Mar; 92(6):657-69. PubMed ID: 7006885
    [No Abstract]   [Full Text] [Related]  

  • 22. Metformin in the treatment of obese diabetics.
    Shenfield GM; Bhalla IP; Steel JM; Duncan LJ
    Practitioner; 1977 Nov; 219(1313):745-9. PubMed ID: 594027
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of a single dose of metformin on glucose tolerance in normal and obese patients].
    Vague P
    Diabete; 1970; 18(1):35-9. PubMed ID: 5509648
    [No Abstract]   [Full Text] [Related]  

  • 24. [The biguanides in the treatment of late florid diabetes of recent diagnosis: controlled trial of delayed-action buformin and placebo].
    Angeli G; Baraldi B; Ciaramelli F
    Clin Ter; 1977 Jun; 81(5):453-62. PubMed ID: 328220
    [No Abstract]   [Full Text] [Related]  

  • 25. [Research on the euglycemic effect of a new, delayed-action phenformin in florid diabetic patients during oral glucose tolerance test].
    Vailati G; Cuttica F; Montini M; Rebba A; Pagani G
    Clin Ter; 1974 Jan; 68(2):149-70. PubMed ID: 4596250
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results in diabetic therapy with Silubin retard. 3].
    Kopp H
    Med Klin; 1971 Feb; 66(7):246-7. PubMed ID: 5552720
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
    Fanghänel G; Silva U; Sanchez-Reyes L; Sisson D; Sotres D; Torres EM
    Rev Invest Clin; 1998; 50(5):389-94. PubMed ID: 9949668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic possibilities in diabetes mellitus with biguanides. Clinical experiences in 122 diabetics with dimethylbiguanide(Glucophage)].
    Berger W; Constam GR; Siegenthaler W
    Schweiz Med Wochenschr; 1966 Oct; 96(40):1335-42. PubMed ID: 5954279
    [No Abstract]   [Full Text] [Related]  

  • 29. [Round-table discussion on the value of the association of chlorpropamide with metformin in the treatment of diabetes mellitus].
    J Med Lyon; 1972 Feb; 53(222):153-6 passim. PubMed ID: 5046640
    [No Abstract]   [Full Text] [Related]  

  • 30. [Value of delayed-action metformin in the treatment of diabetes].
    Pousset G; Robert M; Guinet P
    Lyon Med; 1971 Sep; 226(14):219-21. PubMed ID: 5117728
    [No Abstract]   [Full Text] [Related]  

  • 31. The treatment and progress of obese insulin independent diabetics.
    Borsey DQ; Fraser DM; Duncan LJ
    Practitioner; 1979 Nov; 223(1337):678-81. PubMed ID: 530924
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of diabetes mellitus with the E.R. 105 oral preparation].
    Domingo Gutiérrez AJ
    Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the use of ER 102 in the treatment of diabetes mellitus].
    Selvini A; Brugi A; Emanueli A
    Minerva Med; 1967 Jan; 58(7):189-96. PubMed ID: 6018158
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the effect of delayed-action metformin in continuous blood sugar recording].
    Lapinski H; Mirouze J
    Diabete; 1971; 19(2):121-4. PubMed ID: 5115582
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes of fibrinolytic activity in obese diabetics during treatment with delayed-action Silubin].
    Mincu I; Dumitrescu C; Mihalache N
    Med Interna (Bucur); 1972 Dec; 24(12):1421-4. PubMed ID: 4655564
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with DB retard in therapy of diabetes].
    Grujić M; Perinović M
    Med Welt; 1975 Mar; 26(12):571-3. PubMed ID: 1134297
    [No Abstract]   [Full Text] [Related]  

  • 38. Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention.
    Kao J; Tobis J; McClelland RL; Heaton MR; Davis BR; Holmes DR; Currier JW;
    Am J Cardiol; 2004 Jun; 93(11):1347-50, A5. PubMed ID: 15165912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
    Wilton D
    Postgrad Med J; 1975; 51 Suppl 1():138-9. PubMed ID: 1219673
    [No Abstract]   [Full Text] [Related]  

  • 40. [4 years of clinical experience with metformin in 47 diabetic patients].
    Joncas F
    Union Med Can; 1972 Jan; 101(1):65-70. PubMed ID: 5013455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.